Status | Study |
Not yet recruiting |
Study Name: Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial Condition: Dyspnea Date: 2017-05-10 Interventions: Drug: Sirolimus mTOR inhibitor or placebo Other Name |
Not yet recruiting |
Study Name: LAM Pilot Study With Imatinib Mesylate Condition: Lymphangioleiomyomatosis Date: 2017-04-24 Interventions: Drug: Imatinib Mesylate 400Mg Capsule |
Not yet recruiting |
Study Name: Trabectedin Maintenance Post 1st-line in STS Condition: Sarcoma, Soft Tissue Date: 2016-10-07 Interventions: Drug: Trabectedin Trabectedin 1.2 mg/m² through a central venous catheter as an IV infusion over 24 |
Recruiting |
Study Name: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) Condition: Lymphangioleiomyomatosis Date: 2016-10-07 Interventions: Drug: Nintedanib Other Name: OFEV |
Recruiting |
Study Name: Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France Condition: Tuberous Sclerosis Complex Date: 2016-08-30 |
Recruiting |
Study Name: The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients Condition: Interstitial Pulmonary Fibrosis ARDS COPD (Chronic Obstructive Pulmonary Disease) Date: 2016-07-21 Interventions: Procedure: Veno-veno-arterial ECMO |
Recruiting |
Study Name: Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis Condition: Pulmonary Lymphangioleiomyomatosis Date: 2016-03-31 Interventions: Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi |
Recruiting |
Study Name: Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Condition: Sporadic Angiomyolipomas (AMLs) Date: 2015-08-20 Interventions: Drug: Everolimus 10 mg tablets |
Recruiting |
Study Name: A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa Condition: PEComa Date: 2015-07-08 Interventions: Drug: ABI-009 |
Recruiting |
Study Name: COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC Condition: Lymphangioleiomyomatosis (LAM) Date: 2015-06-25 Interventions: Drug: Celecoxib We will perform a pilot clinical trial to investigate the safety and tolerability of cel |